Price Alert

National Health Investors... (NHI)

NYSE: NHI · Real-Time Price · USD

74.25

0.00 (0.00%)

At close: Aug 15, 2025, 10:00 AM

National Health Investors Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	349.38M	342.96M	335.18M	328.89M	326.05M	318.96M	319.83M	311.04M	307.23M	289.25M	278.19M	277.19M	274.73M	289.16M	298.72M	310.29M	320.75M	330.6M
Cost of Revenue	42.47M	11.32M	11.16M	11.1M	11.22M	11.63M	11.51M	10.97M	10.42M	9.37M	9.79M	11.67M	12.5M	12.51M	11.64M	9.98M	10.99M	10.26M
Gross Profit	306.91M	331.65M	324.02M	317.8M	314.84M	307.33M	308.32M	300.07M	296.81M	279.89M	268.41M	265.52M	262.23M	276.64M	287.08M	300.31M	309.77M	320.34M
Operating Income	188.37M	186.46M	183.85M	187.25M	140.94M	133.53M	135.07M	124.72M	166.63M	144.97M	113.13M	95.29M	77.36M	103.77M	138.42M	174.47M	206.57M	218.91M
Interest Income	n/a	n/a	n/a	n/a	15.09M	29.28M	43.31M	42.69M	27.61M	13.41M	-616K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	141.49M	139.75M	136.59M	125.65M	126.44M	130.93M	134.46M	104.22M	109.42M	91.44M	65.5M	70.45M	67.07M	84.83M	111.97M	142.63M	154.44M	159.63M
Net Income	142.93M	141.2M	137.99M	126.79M	127.59M	132.12M	108.95M	78.77M	83.89M	55.32M	46.23M	50.85M	47.19M	75.16M	111.81M	142.47M	154.25M	159.44M
Selling & General & Admin	25.26M	24.17M	21.79M	21.03M	20.48M	19.92M	19.82M	19.93M	20.26M	21.17M	25.32M	24.05M	22.99M	21.15M	19.34M	19.04M	18.3M	18.03M
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	93.05M	121.02M	118.37M	85.93M	55.58M	27.44M	27.4M	88.94M	79.36M	110.73M	126.18M	63.27M	117.3M	108.21M	86.15M	106.83M	85.12M	83.86M
Operating Expenses	122.58M	145.19M	140.16M	132.11M	130.52M	129.66M	129.53M	166.02M	165.79M	170.23M	189.83M	173.12M	187.76M	176.82M	152.96M	125.83M	103.2M	101.43M
Interest Expense	14.03M	28.01M	42.05M	28.03M	42.4M	42M	41.98M	53.81M	39.45M	25.86M	11.83M	12.28M	12.28M	12.28M	12.28M	12.29M	12.29M	12.29M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	161.02M	156.51M	151.33M	143.21M	141.74M	141.29M	141.04M	176.99M	176.21M	179.6M	199.62M	184.79M	200.25M	189.34M	164.6M	135.82M	114.18M	111.69M
Income Tax Expense	-45K	-45K	-45K	16.17M	28.46M	41.55M	67.96M	51.79M	39.5M	36.66M	19.81M	31.46M	43.01M	32.76M	23.2M	11.39M	-162K	-162K
Shares Outstanding (Basic)	46.69M	45.72M	45.12M	43.48M	43.4M	43.39M	43.39M	43.39M	43.39M	43.39M	43.39M	44.34M	45.71M	45.85M	45.85M	45.85M	45.85M	45.31M
Shares Outstanding (Diluted)	46.82M	45.88M	45.44M	43.99M	43.56M	43.42M	43.39M	43.39M	43.39M	43.39M	43.39M	44.4M	45.72M	45.85M	45.85M	45.85M	45.86M	45.36M
EPS (Basic)	3.16	3.18	3.14	2.92	2.94	3.05	2.52	1.82	1.92	1.25	1.04	1.14	1.03	1.63	2.44	3.13	3.41	3.55
EPS (Diluted)	3.13	3.15	3.12	2.91	2.94	3.05	2.52	1.82	1.92	1.25	1.04	1.14	1.03	1.63	2.44	3.13	3.41	3.55
EBITDA	273.56M	268.28M	264.16M	252.13M	255.5M	248.55M	250.77M	218.04M	214.24M	192.62M	161.44M	162.26M	144.84M	172.02M	207.29M	249.86M	283.83M	297.24M
EBIT	197.32M	195.18M	192.71M	180.53M	183.43M	177.19M	179M	147.8M	147.63M	130.52M	101.15M	99.72M	77.13M	96.19M	127.01M	163.68M	195.79M	208.4M
Depreciation & Amortization	76.25M	73.09M	71.44M	70.6M	71.07M	72.08M	72.49M	71.96M	71.26M	77.69M	78.3M	80.55M	82.8M	78.25M	80.28M	81.75M	82.8M	83.25M